VoxNeuro wins FDA 510(k) clearance for cfNI EEG analysis software

The company is also working with Stillwater Capital to pursue a strategic acquirer as it looks to scale clinical adoption of its prescription-use neuroimaging software.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.